Literature DB >> 22049245

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.

Maria Rossing1, Rehannah Borup, Ricardo Henao, Ole Winther, Jonas Vikesaa, Omid Niazi, Christian Godballe, Annelise Krogdahl, Martin Glud, Christian Hjort-Sørensen, Katalin Kiss, Finn Noe Bennedbæk, Finn Cilius Nielsen.   

Abstract

The molecular determinants of thyroid follicular nodules are incompletely understood and assessment of malignancy is a diagnostic challenge. Since microRNA (miRNA) analyses could provide new leads to malignant progression, we characterised the global miRNA expression in follicular adenoma (FA) and follicular carcinoma (FC). Comparison of carcinoma and adenoma with normal thyroid revealed 150 and 107 differentially expressed miRNAs respectively. Most miRNAs were down-regulated and especially miR-199b-5p and miR-144 which were essentially lost in the carcinomas. Integration of the changed miRNAs with differentially expressed mRNAs demonstrated an enrichment of seed sites among up-regulated transcripts encoding proteins implicated in thyroid tumourigenesis. This was substantiated by the demonstration that pre-miR-199b reduced proliferation when added to cultured follicular thyroid carcinoma cells. The down-regulated miRNAs in FC exhibited a substantial similarity with down-regulated miRNAs in anaplastic carcinoma (AC) and by gene set enrichment analysis, we observed a significant identity between target mRNAs in FC and transcripts up-regulated in AC. To examine the diagnostic potential of miRNA expression pattern in distinguishing malignant from benign nodules we employed a supervised learning algorithm and leave-one-out-cross-validation. By this procedure, FA and FC were identified with a negative predicted value of 83% (data generated by microarray platform) and of 92% (data generated by qRT-PCR platform). We conclude that follicular neoplasia is associated with major changes in miRNA expression that may promote malignant transformation by increasing the expression of transcripts encoding tumourigenic factors. Moreover, miRNA profiling may facilitate the diagnosis of carcinoma vs adenoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22049245     DOI: 10.1530/JME-11-0039

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  41 in total

Review 1.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

2.  MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.

Authors:  Veronika Mancikova; Esmeralda Castelblanco; Elena Pineiro-Yanez; Javier Perales-Paton; Aguirre A de Cubas; Lucia Inglada-Perez; Xavier Matias-Guiu; Ismael Capel; Maria Bella; Enrique Lerma; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Francisco Maravall; Didac Mauricio; Fatima Al-Shahrour; Mercedes Robledo
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

3.  MicroRNA expression profiles in differentiated thyroid cancer, a review.

Authors:  Xinying Li; Asim B Abdel-Mageed; Debasis Mondal; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2012-11-18

4.  Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.

Authors:  Jing Liu; Liguo Feng; Haitao Zhang; Jin Zhang; Yanyan Zhang; Shujing Li; Long Qin; Ziyao Yang; Jianxia Xiong
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

5.  MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Authors:  Hongbin Bao; Xinguo Li; Hengli Li; Hongli Xing; Binghui Xu; Xianfeng Zhang; Zhaoming Liu
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

6.  Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

Authors:  Luisa Vicari; Cristina Colarossi; Dario Giuffrida; Ruggero De Maria; Lorenzo Memeo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

7.  Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Authors:  Hongyu Guan; Weiwei Liang; Zhiwei Xie; Hai Li; Juan Liu; Liehua Liu; Lingling Xiu; Yanbing Li
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

8.  miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression.

Authors:  Yuan-Fei Ren; Tie-Hui Zhang; Sheng Zhong; Yan-Tao Zhao; Ya-Nan Lv
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

Review 9.  BANCR: a cancer-related long non-coding RNA.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

10.  MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.

Authors:  Jia-Ying Fan; Yan Yang; Jing-Ying Xie; Yan-Ling Lu; Kun Shi; Yan-Qing Huang
Journal:  Tumour Biol       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.